LIVN - LivaNova gains regulatory nod for blood monitoring device
2023-08-31 08:59:49 ET
More on LivaNova
- LivaNova: Struggling To Eye Value At Current Multiples, Reiterate Hold
- LivaNova PLC ( LIVN ) Q2 2023 Earnings Call Transcript
- LivaNova PLC 2023 Q2 - Results - Earnings Call Presentation
- LivaNova PLC beats Q2 top and bottom line estimates; raises FY23 outlook
- LivaNova ticks higher amid vague takeover speculation
- FDA labels recall of blood bypass pump systems by LivaNova as most serious
- LivaNova PLC Non-GAAP EPS of $0.53 beats by $0.01, revenue of $254.2M beats by $4.65M, lowers FY earning guidance
- Seeking Alpha’s Quant Rating on LivaNova PLC
- Earnings data for LivaNova PLC
For further details see:
LivaNova gains regulatory nod for blood monitoring device